Alas HJA, Barillas RS

Language: Spanish
References: 15
Page: 1-8
PDF size: 159.15 Kb.

ABSTRACT

Premenstrual dysphoric syndrome is a disorder that affects various spheres of life, causing functional impairment. In its etiology, dysregulation of hormones and neurotransmitters is involved, for its diagnosis the criteria of the Diagnostic and Statistical Manual of Mental Disorders, the DSM-V, are used. Antidepressant treatment is considered the first line of treatment; the use of anovulatory agents such as contraceptives and gonadotropinreleasing hormone agonists, can be considered especially in patients who require fertility control and symptom management. Surgery is considered the last line of treatment for patients with severe and difficult to control symptoms. There are other therapies such as alloprenanolone, cognitive behavioral therapy, diet and exercise that require future research to determine their benefit in the management of this disorder..

REFERENCES

1. Bosman, R., Jung, S., Miloserdov, K., Schoevers, R. and aan het Rot, M., 2016. Daily symptom ratings for studying premenstrual dysphoric disorder: A review. Journal of Affective Disorders, 189, pp.43-53. https://doi.org/10.1016/j.jad.2015.08.063

2. Reid, R. and Soares, C., 2018. Premenstrual Dysphoric Disorder: Contemporary Diagnosis and Management. Journal of Obstetrics and Gynaecology Canada, 40(2), pp.215-223. https://doi.org/10.1016/j.jogc.2017.05.018

3. Lanza di Scalea, T. and Pearlstein, T., 2017. Premenstrual Dysphoric Disorder. Psychiatric Clinics of North America, 40(2), pp.201-216. https://doi.org/10.1016/j.psc.2017.01.002

4. Andrade C. Premenstrual dysphoric disorder: General overview, treatment strategies, and focus on sertraline for symptom-onset dosing. Indian Journal of Psychiatry. 2016;58(3):329. https://doi.org/10.4103/0019-5545.192014

5. Pearlstein T. Treatment of Premenstrual Dysphoric Disorder: Therapeutic Challenges. Expert Review of Clinical Pharmacology. 2016;9(4):493-496. https://doi.org/10.1586/17512433.2016.1142371

6. Sepede, G., Sarchione, F., Matarazzo, I., Di Giannantonio, M. and Salerno, R., 2016. Premenstrual Dysphoric Disorder Without Comorbid Psychiatric Conditions. Clinical Neuropharmacology, 39(5), pp.241- 261. https://doi.org/10.1097/WNF.0000000000000173

7. Hofmeister S, Bodden S. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. American Family Physician. 2016;94(3):236-240.

8. Appleton S. Premenstrual Syndrome. Clinical Obstetrics and Gynecology. 2018;61(1):52- 61.https://doi.org/10.1097/GRF.0000000000000339

9. McEvoy K, Osborne L, Nanavati J, Payne J. Reproductive Affective Disorders: a Review of the Genetic Evidence for Premenstrual Dysphoric Disorder and Postpartum Depression. Current Psychiatry Reports. 2017;19(12).https://doi.org/10.1007/s11920-017-0852-0

10. Yamada K. High prevalence of menstrual migraine comorbidity in patients with premenstrual dysphoric disorder: Retrospective survey. Cephalalgia. 2015;36(3):294-295. https://doi.org/10.1177/0333102415586066

11. Hantsoo L, Epperson C. Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Current Psychiatry Reports. 2015;17(11).https://doi.org/10.1007/s11920-015-0628-3

12. . Carlini S, Deligiannidis K. Evidence-Based Treatment of Premenstrual Dysphoric Disorder. The Journal of Clinical Psychiatry. 2020;81(2).https://doi.org/10.4088/JCP.19ac13071

13. Lete I, Lapuente O. Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review. Open Access Journal of Contraception. 2016;Volume 7:117- 125.https://doi.org/10.2147/OAJC.S97013

14. Maharaj S, Trevino K. A Comprehensive Review of Treatment Options for Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Journal of Psychiatric Practice. 2015;21(5):334- 350.https://doi.org/10.1097/PRA.0000000000000099

15. Ryu A, Kim T. Premenstrual syndrome: A mini review. Maturitas. 2015;82(4):436-440. https://doi.org/10.1016/j.maturitas.2015.08.010